220 related articles for article (PubMed ID: 22567849)
1. [Mycobacterium tuberculosis mutants with multidrug resistance: history of origin, genetic and molecular mechanisms of resistance, and emerging challenges].
Prozorov AA; Zaĭchikova MV; Danilenko VN
Genetika; 2012 Jan; 48(1):5-20. PubMed ID: 22567849
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Zhang Y; Yew WW
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
[TBL] [Abstract][Full Text] [Related]
3. [Tuberculosis caused by XDR resistant Mycobacterium tuberculosis in Poland. Microbiological and molecular analysis].
Augustynowicz-Kopeć E; Zwolska Z
Pneumonol Alergol Pol; 2007; 75(1):32-9. PubMed ID: 17541910
[TBL] [Abstract][Full Text] [Related]
4. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
[TBL] [Abstract][Full Text] [Related]
5. Genomic sequence based scanning for drug resistance-associated mutations and evolutionary analysis of multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis.
Liu CH; Li HM; Lu N; Wang Q; Hu YL; Yang X; Hu YF; Woo PC; Gao GF; Zhu B
J Infect; 2012 Nov; 65(5):412-22. PubMed ID: 22728171
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
Ahmad S; Mokaddas E
Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
[TBL] [Abstract][Full Text] [Related]
7. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
[TBL] [Abstract][Full Text] [Related]
8. [Molecular-genetic characteristics of Mycobacterium tuberculosis strains isolated in southern region of Ukraine].
Nikolaevskiĭ VV; Drobniewski FA; Bazhora IuI
Tsitol Genet; 2004; 38(4):23-8. PubMed ID: 15715161
[TBL] [Abstract][Full Text] [Related]
9. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
10. From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition.
Perdigão J; Macedo R; Silva C; Machado D; Couto I; Viveiros M; Jordao L; Portugal I
J Antimicrob Chemother; 2013 Jan; 68(1):27-33. PubMed ID: 23054995
[TBL] [Abstract][Full Text] [Related]
11. Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.
Schaaf HS; Victor TC; Venter A; Brittle W; Jordaan AM; Hesseling AC; Marais BJ; van Helden PD; Donald PR
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1355-9. PubMed ID: 19861006
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of drug resistance in Mycobacterium tuberculosis and current status of rapid molecular diagnostic testing.
Laurenzo D; Mousa SA
Acta Trop; 2011 Jul; 119(1):5-10. PubMed ID: 21515239
[TBL] [Abstract][Full Text] [Related]
13. Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic.
Minime-Lingoupou F; Pierre-Audigier C; Kassa-Kélémbho E; Barilone N; Zandanga G; Rauzier J; Cadet-Daniel V; Le Faou A; Gicquel B
Int J Tuberc Lung Dis; 2010 Jun; 14(6):782-5. PubMed ID: 20487620
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistant tuberculosis: past, present, future.
Chiang CY; Centis R; Migliori GB
Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
[TBL] [Abstract][Full Text] [Related]
16. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
Chiang CY
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
[No Abstract] [Full Text] [Related]
17. [Clinical value of microchip technology in determination of drug resistance of Mycobacterium tuberculosis].
Vasil'eva IA; Chernousova LN; Zasedatelev AS; Sobolev AIu; Mikhaĭlovich VM
Probl Tuberk; 2002; (6):21-4. PubMed ID: 12227044
[TBL] [Abstract][Full Text] [Related]
18. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.
Gagneux S; Long CD; Small PM; Van T; Schoolnik GK; Bohannan BJ
Science; 2006 Jun; 312(5782):1944-6. PubMed ID: 16809538
[TBL] [Abstract][Full Text] [Related]
19. [Primary drug-resistance is the main cause of drug-resistant tuberculosis].
Mei J; Xue Z; Shen X; Shen GM; Gui XH; Shen M; Gao Q
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Feb; 29(2):75-8. PubMed ID: 16677445
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphisms may explain the contrasting phenotypes of two variants of a multidrug-resistant Mycobacterium tuberculosis strain.
Bigi MM; Lopez B; Blanco FC; Sasiain MD; De la Barrera S; Marti MA; Sosa EJ; Fernández Do Porto DA; Ritacco V; Bigi F; Soria MA
Tuberculosis (Edinb); 2017 Mar; 103():28-36. PubMed ID: 28237031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
